PHASE4 VENTURES

phase4-ventures-logo

Phase4 Ventures is a venture capital firm based in London that invests in development stage life science companies in the US and Europe. Founded in 1999, the team has made close to 30 investments in Life Science companies alongside other top tier venture capital firms in both Europe and the US. The team is complemented by an extensive group of advisors with operating experience at a senior level in pharmaceutical and biotechnology companies. Phase4 Ventures' investments include many of the compa... nies that have provided successful European and US venture exits including Intercell, Pharmion, Targacept and most recently Proteolix. Phase4 Ventures was spun-out from Nomura in December 2010 following a buy out of the management company by the team and a secondary purchase of a fund by HarbourVest Partners. Phase4 Ventures currently manages funds for both Nomura and HarbourVest. Phase4 Ventures Limited is a member of the British Private Equity and Venture Capital Association (BVCA) and the European Private Equity and Venture Capital Association (EVCA).

#Financial #More

PHASE4 VENTURES

Industry:
Finance Financial Services Venture Capital

Founded:
1999-01-01

Status:
Closed

Contact:
44 203 036 0050


Investments List

Date Company Article Money raised
2009-08-06 Zosano Pharma Phase4 Ventures investment in Series B - Zosano Pharma 30 M USD
2008-11-04 OncoMed Pharmaceuticals Phase4 Ventures investment in Series B - OncoMed Pharmaceuticals 154 M USD
2008-09-08 Proteolix Phase4 Ventures investment in Series C - Proteolix 79 M USD
2007-11-15 Zosano Pharma Phase4 Ventures investment in Series A - Zosano Pharma 90 M USD
2007-09-04 Nabriva Therapeutics Phase4 Ventures investment in Venture Round - Nabriva Therapeutics 56 M USD
2007-03-08 Phenomix Phase4 Ventures investment in Series C - Phenomix 55 M USD
2006-04-03 Chroma Therapeutics Phase4 Ventures investment in Series C - Chroma Therapeutics 53 M USD
2006-02-10 ARYx Therapeutics Phase4 Ventures investment in Series E - ARYx Therapeutics 30.4 M USD
2005-10-26 Cerimon Pharmaceuticals Phase4 Ventures investment in Series A - Cerimon Pharmaceuticals 70 M USD
2004-06-01 ARYx Therapeutics Phase4 Ventures investment in Series D - ARYx Therapeutics 55 M USD

More informations about "Phase4 Ventures" on Search Engine